Natus Medical, Inc. (NASDAQ:BABY)

CAPS Rating: 4 out of 5

A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.

Results 1 - 20 of 143 : 1 2 3 4 5 6 7 8 Next »

Recs

0
Member Avatar sparkplug41 (< 20) Submitted: 2/25/2014 3:53:15 AM : Outperform Start Price: $26.14 BABY Score: +0.68

Parents are always worried about their children and are willing to shell out.

Recs

0
Member Avatar QualityPicks (63.56) Submitted: 2/18/2014 9:02:47 PM : Outperform Start Price: $25.58 BABY Score: +2.29

This company has a god valuation and it seems that now it will have growth. If that is the case, this will be a nice stock.

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 4:35:38 PM : Underperform Start Price: $13.57 BABY Score: -88.43

Long. Medical equipment for newborn care. Trading at 15x fye earnings estimates. Revenues up 35% last quarter. Beat analyst estimates past 4 quarters.

Recs

0
Member Avatar surabayajhonny (64.17) Submitted: 11/10/2011 5:07:09 PM : Outperform Start Price: $8.22 BABY Score: +184.84

Hidden Gem

Recs

0
Member Avatar zientsa (37.22) Submitted: 10/13/2010 12:41:35 PM : Outperform Start Price: $14.79 BABY Score: +22.97

Good management, expanding in the neonatalogy arena, making strategic accretive acquisitions

Recs

0
Member Avatar jfbrat (< 20) Submitted: 5/22/2010 12:10:41 PM : Outperform Start Price: $15.97 BABY Score: -6.18

is the largest, continues to expand and is in good position to increase its testing and add new products

Recs

0
Member Avatar JMJeffrey (68.70) Submitted: 2/5/2010 11:58:58 AM : Outperform Start Price: $13.00 BABY Score: +29.63

Before this BABY gets thrown out with the bathwater I am going to purchase a few shares. I like the space where BABY operates and believe that the market is there for their products. Just need a little more economic wind behind them.

Recs

0
Member Avatar FinanceGuy58 (55.61) Submitted: 1/4/2010 6:15:01 PM : Outperform Start Price: $14.94 BABY Score: +13.58

BABY is executing on a strategy of growth by acquisition. I like to think of them as the next Cytyc.

Recs

0
Member Avatar IsleGirl2010 (97.32) Submitted: 11/13/2009 12:50:40 PM : Outperform Start Price: $14.31 BABY Score: +16.64

small cap company with potential.

Recs

0
Member Avatar ZEEMOTLEEFEWL (28.52) Submitted: 10/8/2009 8:41:59 AM : Outperform Start Price: $15.50 BABY Score: -4.21

hidden gem, 5-star, healthcare technology

Recs

0
Member Avatar Contralogic (< 20) Submitted: 9/18/2009 1:34:37 PM : Outperform Start Price: $16.81 BABY Score: -17.74

Solid track record of acquisition integration, expansion into European market.

Recs

0
Member Avatar tixareforkids (36.80) Submitted: 9/15/2009 11:53:48 AM : Outperform Start Price: $16.91 BABY Score: -22.12

Many smart fools

Recs

0
Member Avatar lotsa (< 20) Submitted: 8/6/2009 10:03:01 PM : Outperform Start Price: $14.10 BABY Score: +2.55

baby heatlh care products, good company

Recs

0
Member Avatar BlackberryIsland (< 20) Submitted: 5/20/2009 3:45:16 PM : Outperform Start Price: $9.33 BABY Score: +80.81

technological edge

Recs

1
Member Avatar 21popsontop (< 20) Submitted: 4/29/2009 11:31:49 PM : Outperform Start Price: $8.52 BABY Score: +104.40

Natus Medical Incorporated/ AKA (BABY) is a provider of healthcare products for the monitoring, screening,detection,treatment,and tracking of (common) medical ailments in the you better care for my newborn's industry. Everything from hearing impairments,neurological dysfunctions,from epilepsy,sleep disorders to balance and mobility disorders. To date products include computerized neurodiagnostic systems for audiology,neurology,polysomnography,and neonatology,as well as care products and phototherapy devices for treatment of newborn jaundice,head cooling products for the treatment of brain injury in newborns and software systems for tracking and managing diseases and disorders for public health laboratories.After having two full grown son's behind me,this company looks like a long term winner to keep mother and father happy with the medical care of their newborn and should be considered under $10. $230 market cap PE around 13.00 REO around 11.00 Net profit around 12% and a sum of free cash on hand with low dept. One to watch for sure.

Recs

0
Member Avatar JJGold26 (99.10) Submitted: 4/7/2009 6:49:42 PM : Outperform Start Price: $8.02 BABY Score: +107.05

Healthy balance sheet but going through rough times right now with hospital spending down. I'm thinking at least a double by 3 years from now.

Recs

0
Member Avatar StarWitchDoctor (99.46) Submitted: 2/27/2009 1:50:17 PM : Outperform Start Price: $7.89 BABY Score: +87.89

healthcare took a beating recently, it would not be prudent to assume all we have heard will become reality. You cannot buy healthcare for nothing Obama. Its not for sale that cheap. Dont care if you buy a unit of health for all of it, but as a taxpayer, if you do, i had better get my share.

Recs

1
Member Avatar cfackler (95.37) Submitted: 2/24/2009 10:11:47 AM : Outperform Start Price: $7.94 BABY Score: +86.58

Another long term buying opportunity. Great balance sheet.
Qtrly Earnings Growth (yoy): 51.80%
Total Cash (mrq): 68.98M
Total Debt (mrq): 1.54M

I like to see the insider ownership a little higher than 1.81% but everything else looks great and it's trading near a 52 week low.

Recs

0
Member Avatar ditto1940 (82.35) Submitted: 2/22/2009 2:33:23 PM : Outperform Start Price: $8.50 BABY Score: +73.62

analysts are neutral on this stock now but it seems to have potential in an up market. This company develops medical monitoring equipment for infants and operates primarily in the United States. That should leave a lot of room for growth.

Recs

0
Member Avatar fdude71 (71.40) Submitted: 2/20/2009 11:55:30 AM : Outperform Start Price: $8.40 BABY Score: +73.00

Fairly decent valuation... I think this will get close to $7 then come back up.
Not trying to pick this one up at the bottm as it is fairly certain it will grow quite a bit in the long run.

Company operates in a good sector... management is well respected and its a CAPS 5 stars.

Featured Broker Partners


Advertisement